FOMAT

Early phase studies with real-world execution

Phase I-unit capabilities

A dedicated Phase I unit embedded in active care settings, equipped to run complex Phase I studies with close follow up, rapid decisions, and reliable data.
Facility and staffing

✓ 11 inpatient beds for confinement and intensive schedules
✓ Around-the-clock coverage by licensed medical staff
✓ Participant areas set for multi-day stays, with private bathrooms and showers

Pharmacy and lab on site

✓ On-site pharmacy with secure storage and biosafety cabinet
✓ PBMC laboratory for controlled sample handling and storage
✓ IATA certified sample handling
✓ CLIA-supported safety laboratory

Study scope

✓ BA and BE, PK and PD, ADME and ethno bridging
✓ First in human, dose escalation, and device-focused protocols
✓ Fast access to diagnostic and imaging centers
✓ Ability to run chronic oncology and chronic condition studies

Phase I deliver in numbers

These results reflect mature recruitment pathways, engaged investigators, and a setup that keeps participants in the study through confinement and follow-up.

Participant retention
0 %
Days from site activation to first participant
0

Participant experience and safety 

Retention-focused environment for confined and high-touch studies.

  • Private patient rooms with room recliners and beds
  • Dedicated patient bathrooms with showers
  • Assessment room for procedures and safety checks
  • Conference room for study team huddles and reviews
  • Patient retention amenities including Wi Fi, meal delivery, and recreational spaces

Stepping beyond Phase I

Early work in this unit can transition into Phase II to III across our outpatient and community sites, maintaining continuity in team and processes.